Biomarker study for biologics in chronic sinusitis with nasal polyps
Treatments studied
Part of Ear, nose & throat, Immune system & allergy clinical trials.
This study is looking for markers in the blood that can predict how well certain biologic drugs work for people with chronic sinusitis and nasal polyps. It may help find the right treatment for you if your symptoms are not controlled with standard sprays or after surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old
- You have nasal polyps in both nostrils that are moderate to severe (score 4 or higher on a 0-8 scale)
- Your nasal congestion is at least moderate (score 2 or higher, where 0-3 scale)
- You have used steroid nasal spray regularly for at least 4 weeks
- You have had symptoms like stuffy nose and loss of smell or runny nose for at least 4 weeks
- You have had prednisone pills within the last 2 years, or cannot take them, or had nasal polyp surgery more than 6 months ago
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a new medication called stapokibart, given before endoscopic sinus surgery, helps treat chronic rhinosinusitis with nasal polyps (a condition causing persistent nasal congestion, polyps in the sinuses, and loss of smell). The goal is to see if this medication reduces symptoms and improves surgical outcomes.
This study tests a new drug called BBT002 in healthy people and in patients with chronic sinusitis and nasal polyps, with or without asthma. It aims to see if the drug is safe and effective for reducing symptoms.
This study follows people with chronic rhinosinusitis and nasal polyps who are starting a biologic medication (omalizumab, mepolizumab, or dupilumab) to see how well it works in real life.
This trial tests a new injectable medicine (lebrikizumab) for people with chronic sinusitis and nasal polyps that steroid treatments haven't controlled. It aims to reduce polyp size and improve breathing, smell, and congestion.
This trial compares a newer biologic drug (anti-IL-5) plus simple polyp removal to a more extensive sinus surgery. It's for people with chronic sinusitis and nasal polyps who haven't gotten better with standard treatments.
This trial tests an injectable drug called TQC2731 for people with chronic sinusitis and nasal polyps that haven't been controlled well enough by standard treatments like steroid sprays or surgery. The goal is to see if it helps reduce nasal congestion, improve sense of smell, and shrink polyps.
Hear when a new Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.